As per the research report, the size of the Asia-Pacific Microbial Identification Market size is calculated to approach USD 0.36 billion by 2024 with a CAGR of 6.80%, from the 2019 valuation of USD 0.26 billion during the forecast period 2019-2024.
Microbial identification entails the identification of various kinds of microorganisms that are prone to cause different infectious conditions in humans. In the present world, the major types of microorganisms that cause diseases are parasites, bacteria, fungi and viruses. Their presence contaminates the manufacturing facilities, raw materials and food products.
The growing occurrence of several infections caused by microorganisms is the key driver for the growth of the market. Besides, the increasing consciousness about food safety, coupled with strict regulations and guidelines by government to ensure the cleanliness of surroundings in industries acts a serious promoter for the market growth in future.
This research report segmented and sub-segmented into the following categories:
The Hospitals and Diagnostic Centres segment led the Asia-Pacific market in 2016, owing to the high incidence of various microbial infections.
The Asia-Pacific market is forecast to witness the highest CAGR among all the regions in the forecast period, majorly due to the increasing effort to detect and eliminate the presence of microbes in commercial sector and food sector in the developing countries like India and China in the region.
The Top companies leading in the APAC Microbial Identification Market profiled in the report are Shimadzu Corporation, Dickinson & Company, Biolog Inc., Merck KGaA, IEH Laboratories & Consulting Group, Trivitron Healthcare, Thermo Fisher Scientific Inc., Bruker Corporation, VWR Corporation and Charles River Laboratories International Inc.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Method
5.1.1 Introduction
5.1.2 Genotypic
5.1.3 Proteomics-based
5.1.4 Phenotypic
5.1.5 Y-o-Y Growth Analysis, By Method
5.1.6 Market Attractiveness Analysis, By Method
5.1.7 Market Share Analysis, By Method
5.2 Application
5.2.1 Introduction
5.2.2 F&B
5.2.3 Diagnostic
5.2.4 Pharmaceutical
5.2.5 Environmental
5.2.6 Y-o-Y Growth Analysis, By Application
5.2.7 Market Attractiveness Analysis, By Application
5.2.8 Market Share Analysis, By Application
5.3 Product
5.3.1 Introduction
5.3.2 Identification Services
5.3.3 Consumables
5.3.4 Instruments
5.3.5 Y-o-Y Growth Analysis, By Products and Services
5.3.6 Market Attractiveness Analysis, By Products and Services
5.3.7 Market Share Analysis, By Products and Services
5.4 End User
5.4.1 Food Manufacturing Industries
5.4.2 Pharmaceutical Companies
5.4.3 Hospitals and Diagnostic Centres
5.4.4 Other End users
5.3.5 Y-o-Y Growth Analysis, By End User
5.3.6 Market Attractiveness Analysis, By End User
5.3.7 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Method
6.1.3.3 By Application
6.1.3.4 By Product
6.1.3.5 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Method
6.1.4.3 By Application
6.1.4.4 By Product
6.1.4.5 By End user
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Method
6.1.5.3 By Application
6.1.5.4 By Product
6.1.5.5 By End user
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Shimadzu Corporation
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Dickinson & Company
8.3 Biolog Inc.
8.4 Merck KGaA
8.5 IEH Laboratories & Consulting Group
8.6 Trivitron Healthcare
8.7 Laboratory Corporation of America Holdings
8.8 Thermo Fisher Scientific Inc.
8.9 Bruker Corporation
8.10 Charles River Laboratories
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
